InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Friday, 05/20/2016 5:19:35 AM

Friday, May 20, 2016 5:19:35 AM

Post# of 1194
MBVX has great mAB access but does not financial muscle to test them.

If you see ASCO abstracts - there are so many cancer drugs on trial using mAB

The value of this co is in the IP it owns than the trials - I hope some BP notices them and buys them for decent price.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.